Key references: Pharmacological treatment of personality disorder

  • Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet 2015;385(9969):735–43. https://www.ncbi.nlm.nih.gov/pubmed/25706219
  • Chanen AM, Betts J, Jackson H, McGorry P, Nelson B, Cotton SM, et al. Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial. Early Interv Psychiatry 2019;13(6):1373–81. https://www.ncbi.nlm.nih.gov/pubmed/30689305
  • Chanen AM, Thompson KN. Prescribing and borderline personality disorder. Aust Prescr 2016;39(2):49–53. https://www.ncbi.nlm.nih.gov/pubmed/27340322
  • Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers 2018;4:18029. https://www.ncbi.nlm.nih.gov/pubmed/29795363
  • Gunderson JG, Links PS. Borderline personality disorder: a clinical guide. 2nd ed. Washington, DC: American Psychiatric Press; 2008.
  • Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry 2010;71(1):14–25. https://www.ncbi.nlm.nih.gov/pubmed/19778496
  • Slotema CW, Blom JD, Niemantsverdriet MBA, Sommer IEC. Auditory verbal hallucinations in borderline personality disorder and the efficacy of antipsychotics: a systematic review. Front Psychiatry 2018;9:347. https://www.ncbi.nlm.nih.gov/pubmed/30108529